Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World July 23, 2012 Jennifer Newton	Delivering insulin in a skin cream Scientists in Japan have developed a way to administer insulin to patients through the skin.
The Motley Fool July 27, 2007 Rich Duprey	Sniffing Out Bentley's New Patent To succeed in insulin therapy, the generic drugmaker must overcome patent expiration. Investors, take note.
Chemistry World June 22, 2015 Manisha Lalloo	'Smart patch' set to deliver for diabetes patients A research team has created patches that release insulin in response to changes in oxygen brought about by high glucose levels and hope this could lead to a smarter, painless way of treating the disease.
Chemistry World June 23, 2011 Elinor Richards	One in the eye for diabetes A team in Canada has made a device that could be implanted behind the eye to release drugs on demand to treat retinal damage caused by diabetes.
Chemistry World November 8, 2012 Michael Parkin	Nasal gel alternative to insulin injection Scientists has developed a novel insulin delivery system for nasal administration. The study aims to provide an alternative to regular injections through the delivery of insulin via the nasal membrane in the form of a hydrogel.
Chemistry World February 20, 2014 Laura Howes	Brent Sumerlin: Searching for a sweet response Brent Sumerlin is professor of chemistry at the University of Florida in Gainesville, US. His research concerns the identification, synthesis, and characterization of smart polymers for drug delivery.
Chemistry World August 23, 2013 Jessica Cocker	Plant protein regulates diabetes treatment A plant protein has been used to make a new class of glucose-responsive polymer nanogels that could one day negate the need for diabetes patients to constantly monitor their blood glucose levels and inject themselves with insulin.
American Family Physician October 15, 2001 Anne D. Walling	Family Practice International Diabetes in Patients from the Indian Subcontinent... Diabetic Dermopathy... Managing Minor Wounds in Children... Tibialis Posterior Tendon Insufficiency...
Chemistry World May 7, 2009 Phillip Broadwith	Polymers release insulin in response to glucose trigger Chinese researchers have developed polymer nanoparticles that can release insulin in response to changes in glucose concentration, creating a potential treatment for diabetes.
Nursing November 2009 Christine Kessler	Glycemic control in the hospital: How tight should it be? Based on recent studies, the answer to that question remains controversial. This article will explore this issue and present current best practices for caring for a patient in the hospital who has diabetes or hyperglycemia.
American Family Physician May 1, 2005 David E. Trachtenbarg	Diabetic Ketoacidosis Initial evaluation of patients with DKA includes diagnosis and treatment of precipitating factors. Education to prevent recurrence should be offered to all patients, including how to manage sick days and when to call a physician.
The Motley Fool June 27, 2005 Stephen D. Simpson	Sniffing Out a Possible Diabetes Blockbuster Inhaled insulin has been a Holy Grail of diabetes care. Will it live up to lofty expectations? Pfizer, Sanofi-Aventis, and Lilly are all interesting in their own right as high-quality pharmaceutical companies, and more aggressive investors should take a look at Nektar and Alkermes, as well.
Nurse Practitioner May 2011 Stacey A. Seggelke	Hitting the target for inpatient glycemic management An understanding of glycemic treatment options for hospitalized patients is essential for good patient outcomes.
Scientific American December 12, 2005 Philip E. Ross	Grow Your Own Getting a diabetic pancreas to regrow its islets -- growth factors could restore beta cells lost in type 1 diabetes.
Bio-IT World August 18, 2004 Mark D. Uehling	I, Virtual Patient Along with a software company specializing in modeling diseases on the computer, Roche Diagnostics is working on creating a new biomarker for diabetes that could be reduced to a simple blood test.
American Family Physician January 1, 2003 Jennifer B. Marks	Perioperative Management of Diabetes Diabetic patients who require surgery present special challenges in perioperative management. Special attention must be paid to prevention and treatment of metabolic derangements.
Pharmaceutical Executive May 1, 2009	The Fate of Mannkind Al Mann has sunk almost $1 billion of his own money into a new insulin delivery system. Will FDA be persuaded?
American Family Physician August 1, 2004 Mayfield & White	Insulin Therapy for Type 2 Diabetes: Rescue, Augmentation, and Replacement of Beta-Cell Function New insulin preparations and a better understanding of insulin physiology provide more options for family physicians attempting to effectively tailor insulin therapy to the needs of individual patients.
Pharmaceutical Executive October 1, 2005	Changing Diabetes An interview with Novo Nordisk's president of U.S. operations Martin Soeters on how a nation that leads the world in diabetes research does such a poor job of treating it. Here, he offers some solutions.
Managed Care May 2006 Fadia T. Shaya & Deshpande	New Treatment Approaches To Diabetes The goal of diabetes management is maintaining glycemic control while targeting quality of life improvements.
American Family Physician May 15, 2001 Thomas J. McGinnis	Significant FDA Approvals in 2000 In 2000, the medical product review staffs of the U.S. Food and Drug Administration approved 160 new drugs, biologic products and medical devices for use in the United States. Many of these approvals advance the prevention, diagnosis and treatment of serious and life-threatening diseases...
Science News September 15, 2001	TimeLine: September 12, 1931 Elephant's jawbone shows likeness to scoop shovel... Diabetic patients can eat sugar if fats are eliminated... New simplified formula describes shape of earth...
The Motley Fool January 16, 2008 Brian Lawler	Another Inhalable Insulin Bites the Dust Novo Nordisk discontinues development of its troubled diabetes treatment and settles its patent infringement lawsuit against Pfizer. Investors, take note.
American Family Physician September 15, 2006 Havas & Donner	Tight Control of Type 1 Diabetes: Recommendations for Patients Physicians play an important role in helping type 1 diabetes patients make essential lifestyle changes to help reduce the risk of microvascular and macrovascular complications.
Nursing February 2009 Daniel A. Hussar	New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension.
Managed Care May 2007 Rachel M. Renshaw	Keys to Diabetes Control? Patience, Persistence, and Perseverance Careful attention to a comprehensive treatment plan could forestall or prevent the need to add drugs and costs to a patient's regimen.
American Family Physician November 1, 2002 Robert G. Frykberg	Diabetic Foot Ulcers: Pathogenesis and Management Foot disorders such as ulceration, infection, and gangrene are the leading causes of hospitalization in patients with diabetes mellitus.
Chemistry World September 12, 2010 Mike Brown	Comet shockwaves helped stimulate life on Earth The shock waves caused as comets hit the early Earth could have helped promote the formation of amino acids and the early building blocks of life, say US researchers.
BusinessWeek December 22, 2003 Arlene Weintraub	Big Pharma Looks Beyond Insulin Researchers may be on the verge of major new treatments for diabetes and obesity.
Chemistry World March 8, 2007 Jessica Ebert	How to Catch an Insulin-Doping Athlete A growing number of athletes reportedly take insulin to boost their performance illegally, but controlling insulin abuse has gone largely unchecked. Now, a urine test designed by German and Belgian scientists could be set to change all that.
Nursing October 2010 Jeff Strickler	Traumatic hypovolemic shock: Halt the downward spiral This article discusses the causes, treatments, and nursing care for patients with traumatic hypovolemic shock.
Pharmaceutical Executive March 1, 2006 Ron Feemster	Holding Their Breath: Inhaled Insulin Exubera, Pfizer's inhaled-insulin therapy, is carving out a new market for diabetes drugs. Four more companies are looking for their share.
Nursing June 2011 Daniel A. Hussar	New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis.
Technology Research News June 4, 2003 Eric Smalley	Shock waves tune light Researchers from the Massachusetts Institute of Technology have used a computer simulation to show that sending shock waves through photonic crystals could lead to faster and cheaper telecommunications devices, more efficient solar cells, and advances in quantum computing.
Reactive Reports Issue 67 David Bradley	Fairytale Insulin Substitute People with type I diabetes could one day be prescribed an extract from pumpkins that will drastically cut their reliance on daily insulin injections.
The Motley Fool June 19, 2009 Robert Steyer	MannKind Needs More Leaps Getting FDA approval for its inhaled-insulin product is only one hurdle for this start-up pharmaceutical.
AskMen.com Alex Santoso	What You Should Know About Diabetes Not many men understand what diabetes is, why it's very bad for them (it is one of the leading causes of impotence), what they can do to avoid getting it or how to treat it.
Chemistry World September 3, 2014 Phillip Broadwith	Novo Nordisk quits inflammation R&D and cuts jobs Novo Nordisk is terminating its inflammatory disease R&D programs after the company's leading rheumatoid arthritis drug candidate failed in clinical trials.
The Motley Fool October 2, 2007 Brian Orelli	Amylin's Bittersweet FDA News Diabetes drug moves ahead, but not as much as the company wanted. If the FDA rejection was due to safety issues, that wouldn't bode well for Amylin's plans to develop the active ingredient in SYMLIN as a weight-loss drug. Investors, take note.
HBS Working Knowledge November 23, 2009 Martha Lagace	Management's Role in Reforming Health Care An interview with HBS professor Richard M.J. Bohmer, MD, and an excerpt from his book Designing Care: Aligning the Nature and Management of Health Care.
American Family Physician July 15, 2006 Jennifer D. Goldman-Levine	Insulin Detemir (Levemir) for Diabetes Mellitus Insulin detemir is suitable as basal insulin in a basal-bolus regimen. In limited research, it has been shown to cause slightly fewer episodes of minor hypoglycemia and no weight gain in patients with type 1 and 2 diabetes, which is a benefit that must be balanced against its higher price.
Pharmaceutical Executive November 1, 2014 William Looney	Dane in America Jesper Hoiland, Novo Nordisk's President for North America, assesses the challenges and opportunities during his first year at the helm of the diabetes franchise leader's biggest affiliate market.
American Family Physician July 1, 2005 Micah L. Thorp	Diabetic Nephropathy: Common Questions Diabetic nephropathy, or diabetic kidney disease, affects 20% - 30% of patients with diabetes. This article addresses some of the common questions raised by physicians managing patients with this disease.
American Family Physician June 1, 2005 Aring, Jones & Falko	Evaluation and Prevention of Diabetic Neuropathy The primary types of diabetic neuropathy are sensorimotor and autonomic. Patients may present with only one type of diabetic neuropathy or may develop combinations of neuropathies.
BusinessWeek November 12, 2007 Reena Jana	My iPod, My Cell, My Insulin Pump In an effort to provide better care for the world's surging population of diabetics, medical device makers are teaming up with industrial designers and seeking inspiration in popular consumer products such as MP3 players and cell phones.
Chemistry World June 30, 2014 Phillip Broadwith	Inhaled insulin approved in US Mannkind's Affreza is aimed at reducing the need for patients to inject themselves with insulin so frequently.
The Motley Fool June 27, 2008 Brian Lawler	This Drug Market Is Booming One therapeutic category seems to be expanding significantly faster than most of its peers, the one that helps the unfortunately burgeoning number of diabetics in the U.S. and worldwide.
The Motley Fool March 2, 2005 Bill Mann	How Hated Is Pfizer? The FDA accepts Pfizer's application for what could be a monster drug, and the market yawns.